These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3324721)

  • 1. A double blind clinical trial of Tigason (Ro 10-9359) versus placebo in psoriasis.
    Jakubowicz K; Gruca S; Nowakowski H
    Acta Univ Carol Med (Praha); 1986; 32(3-4):229-32. PubMed ID: 3324721
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of psoriasis with aromatic retinoid derivatives (Tigason) (double-blind method)].
    Gruca S; Jakubowicz K
    Przegl Dermatol; 1984; 71(3):273-8. PubMed ID: 6395197
    [No Abstract]   [Full Text] [Related]  

  • 3. Etretinate (Tigason) and betamethasone valerate (Celeston valerate) in the treatment of psoriasis. A double-blind, randomized, multicenter trial.
    Christiansen JV; Holm P; Møller R; Reymann F; Schmidt H
    Dermatologica; 1982 Sep; 165(3):204-7. PubMed ID: 6751889
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of plaque psoriasis with an aromatic retinoid (etretinate)].
    Melis M
    Rev Med Chil; 1984 Jan; 112(1):20-5. PubMed ID: 6377426
    [No Abstract]   [Full Text] [Related]  

  • 5. Maintenance treatment of psoriasis by Tigason: a double-blind randomized clinical trial.
    Dubertret L; Chastang C; Beylot C; Bazex J; Rognin C; Touraine R
    Br J Dermatol; 1985 Sep; 113(3):323-30. PubMed ID: 3904805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of Tigasone treatment of psoriasis in the light of the experience of the Warsaw Dermatological Clinic].
    Wolska H; Jabłońska S; Langner A; Fraczykowska M
    Przegl Dermatol; 1987; 74(3):216-22. PubMed ID: 3321191
    [No Abstract]   [Full Text] [Related]  

  • 7. [Psoriasis therapy with the aromatic retinoid Ro 10-9359 (Tigason)].
    Sönnichsen N; Harnack K; Barth J; Heilmann S; Jäger K; Metz D; Schiller F
    Z Hautkr; 1983 Sep; 58(17):1257-67. PubMed ID: 6636927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral retinoid for psoriasis. A report of a double blind study.
    Pettit JH
    Acta Derm Venereol Suppl (Stockh); 1979; 59(85):133-6. PubMed ID: 393035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind controlled trial of etretinate (Tigason) and ibuprofen in psoriatic arthritis.
    Hopkins R; Bird HA; Jones H; Hill J; Surrall KE; Astbury C; Miller A; Wright V
    Ann Rheum Dis; 1985 Mar; 44(3):189-93. PubMed ID: 3883917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acitretin in the treatment of severe psoriasis: a randomized double-blind study comparing acitretin and etretinate.
    Meffert H; Sönnichsen N
    Acta Derm Venereol Suppl (Stockh); 1989; 146():176-7. PubMed ID: 2532846
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of treatment with aromatic retinoid (Ro 10-9359) for some diseases with keratinizing disorders.
    Timpatanapong P; Puavilai S; Polnikorn N; Tasanapradit P; Charuwichitratana S
    J Med Assoc Thai; 1985 Feb; 68(2):49-59. PubMed ID: 4009086
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experience with etretinate (Tigason) in 26 patients with psoriasis].
    Gajardo J
    Rev Med Chil; 1989 May; 117(5):516-22. PubMed ID: 2519162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of etretinate (RO-10-9359) in intermittent doses and follow-up for 1 year in patients with psoriasis. Final report].
    Domínguez Soto L; Hokyo Tomoka MT; Armas JJ
    Med Cutan Ibero Lat Am; 1984; 12(1):47-56. PubMed ID: 6376979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of Tigason treatment of children with severe forms of psoriasis and ichthyosis].
    Rosińska D; Wolska H; Konca I
    Przegl Dermatol; 1987; 74(4-5):344-51. PubMed ID: 3329749
    [No Abstract]   [Full Text] [Related]  

  • 15. [Etretinate in the prevention of recurrences of superficial bladder tumors. Clinical trial using the double-blind method].
    Charbit L; Mangin P; Rognin C; Cukier J
    J Urol (Paris); 1983; 89(4):247-9. PubMed ID: 6350479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tigason in the treatment of psoriasis and various dermatoses].
    Kalamkarian AA; Marzeeva GI; Chistiakova IA; Kirsanova MM; Mel'kumov AV
    Vestn Dermatol Venerol; 1985 Jul; (7):4-7. PubMed ID: 4050091
    [No Abstract]   [Full Text] [Related]  

  • 17. Tigason (etretinate) treatment in psoriatic arthritis.
    Ciompi ML; Bazzichi L; Marotta G; Pasero G
    Int J Tissue React; 1988; 10(1):25-7. PubMed ID: 3397251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etretinate therapy causes increases in lipid levels in patients with psoriasis.
    Ellis CN; Swanson NA; Grekin RC; Goldstein NG; Bassett DR; Anderson TF; Voorhees JJ
    Arch Dermatol; 1982 Aug; 118(8):559-62. PubMed ID: 7103524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic treatment of psoriasis with an oral retinoic acid derivative (Ro-10-9359) Tigason.
    Wishart JM; Hodge JL; Greig DE
    N Z Med J; 1981 Oct; 94(694):307-8. PubMed ID: 7033846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment of psoriasis with a new aromatic retinoid (Tigason) in low dosage orally and triamcinolone acetonide cream topically: a double-blind trial.
    van der Rhee HJ; Tijssen JG; Herrmann WA; Waterman AH; Polano MK
    Br J Dermatol; 1980 Feb; 102(2):203-12. PubMed ID: 6992834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.